MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

IRAK-1-4 Inhibitor I

CAS No. : 509093-47-4

MCE 站：IRAK-1-4 Inhibitor I

产品活性：IRAK-1-4 Inhibitor I 是 IRAK1/4 抑制剂，IC₅₀ 分别为 0.2 μM 和 0.3 μM。

研究领域：Immunology/Inflammation

作用靶点：IRAK

In Vitro: IRAK-1-4 Inhibitor I has IC₅₀ greater than the highest concentration tested (10 μM) against a panel of 27 other kinases, including the most closely homologous (outside of the IRAK family) Lck and pp60^SRC. Additionally, IRAK-1-4 Inhibitor I does not show any signs of cytotoxicity in a 72 h proliferation assay in HeLa cells (ED₅₀>30 μM). Significant inhibition of IRAK-1 is observed with IRAK-1-4 Inhibitor I (IRAK-1 IC₅₀=0.3 μM). IRAK-1/4 inhibitor eliminates the LPS-induced increases in Bcl10, NF-κB, and IL-8. IRAK-1/4 mediates LPS-induced IL-8 activation and functions upstream of Bcl10. The LPS-induced increase in Bcl10 declines by 73% (from 5.18±0.22 to 2.36±0.08 ng/mL), and the IL-8 response decline by 60% (from 2.64±0.31 to 1.14±0.08 ng/mL).

相关产品：Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Kinase Inhibitor Library  |  Ginsenoside Rb1  |  AZ1495  |  IRAK4-IN-4  |  IRAK inhibitor 1  |  IRAK inhibitor 2  |  IRAK inhibitor 6  |  IRAK inhibitor 3  |  IRAK inhibitor 4 trans  |  IRAK4-IN-6  |  AS2444697

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。